Journal article
Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women: Results of a Qualitative Study
The Journal of the Association of Nurses in AIDS Care, v 35(5)
13 Aug 2024
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Abstract Long-acting injectable cabotegravir (CAB-LA) was US Food and Drug Administration–approved in 2021. However, little is known about providers' CAB-LA knowledge, attitudes, challenges, and prescribing preferences for transgender women patients. Understanding this is critical to developing new pre-exposure prophylaxis (PrEP) interventions tailored to transgender women. We conducted 45-min, in-depth Zoom interviews (IDIs) with United States–based health care providers who prescribe PrEP to transgender women. IDIs focused on providers' CAB-LA knowledge/acceptability, willingness to prescribe CAB-LA to transgender women, potential challenges, and solutions to mitigate challenges. Providers ( N = 17) had a mean age of 43 years, and 35.4% ( n = 6) identified as people of color. Most ( n = 12) had basic knowledge of CAB-LA but wanted additional training. All participants found CAB-LA acceptable and were willing to prescribe. Most ( n = 11) anticipated minimal challenges to implementation. Others ( n = 4) reported potential issues, including logistical/scheduling concerns that impede CAB-LA integration and staffing concerns. Many providers expressed support for self-injection ( n = 13) and injections at “drop-in” clinics ( n = 8) to overcome challenges.
Metrics
14 Record Views
Details
- Title
- Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women: Results of a Qualitative Study
- Creators
- Christine Tagliaferri Rael - Columbia UniversityDoyel DasJonathan PorterJavier Lopez-RíosElena AbascalCurtis DolezalMichael P. VaughnPilar GiffenigJasmine M. LopezSamantha StonbrakerChristina SunRoque Anthony VelascoLeandra BitterfeldWalter O. BocktingJose Bauermeister
- Publication Details
- The Journal of the Association of Nurses in AIDS Care, v 35(5)
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS; PHILADELPHIA
- Number of pages
- 13
- Grant note
- National Institute of Mental Health: K01 MH115785
C. T. Rael, PhD, is supported by a K01 award (K01 MH115785; Principal Investigator: Christine Tagliaferri Rael) from the National Institute of Mental Health awarded to the University of Colorado College of Nursing (on the Anschutz Medical Campus) and a Gray Matters Fellowship from the Columbia University Department of Psychiatry. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The authors and research team thank all participants for their involvement in this study.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Community Health and Prevention
- Web of Science ID
- WOS:001300485700002
- Scopus ID
- 2-s2.0-85201419232
- Other Identifier
- 991021897245904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Web of Science research areas
- Nursing
- Public, Environmental & Occupational Health